“…Also Oh et al [ 13 ] after a thorough review of the literature, they proposed to reconsider the nomenclature of the tubulopapillary hidradenoma-like tumor of the mandible to be classified as sialadenoma papilliferum-like intraductal papillary tumor. This suggestion based on a comprehensive comparison of its clinico-pathological characteristics, coupled with the identification of two additional cases bearing the BRAF V600E mutation.…”